Saturday 17 October 2026
Export XAGE’s income statement to Excel — free account
Longevity Health Holdings, Inc.
XAGE Consumer Defensive Household & Personal Products
Longevity Health Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 million, up 3,702.8% from fiscal 2024. In the quarter to June 2026, revenue fell 21.4%, EPS grew 51.3% and free cash flow grew 73.2%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
0.11
0.00
0.00%
Follow XAGE
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to December
| Group | Line | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Trend | 2026e | 2027e | 2028e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price, $ | |||||||||||||||
| Price, $ | Low | — | — | — | — | — | 288.00 | 288.00 | 51.00 | 6.00 | 0.30 |
Analyst estimates 2026–2028 Powerpack |
|||
| High | — | — | — | — | — | 302.40 | 298.20 | 399.30 | 120.00 | 36.00 | |||||
| People | |||||||||||||||
| People | Employees | — | — | — | — | — | 0 | — | 9 | 15 | 10 | ||||
| Revenue/emp, $m | — | — | — | — | — | 0.00 | — | 0.00 | 0.00 | 0.19 | |||||
| Income, $m | |||||||||||||||
| Income, $m | Revenue | — | — | — | — | — | — | — | — | 0 | 2 | ||||
| Gross margin, % | — | — | — | — | — | — | — | — | 87.48 | 57.24 | |||||
| EBT | — | — | — | — | — | 0 | (9) | (16) | (11) | (7) | |||||
| EBT margin, % | — | — | — | — | — | 0.00 | 0.00 | 0.00 | (21,367.20) | (359.11) | |||||
| Net income | — | 0 | — | — | — | 0 | (9) | (16) | (11) | (7) | |||||
| Depreciation | — | — | — | — | — | — | 2 | 0 | 0 | 0 | |||||
| Per share, $ | |||||||||||||||
| Per share, $ | Revenue | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.07 | 1.34 | ||||
| Earnings | — | — | — | — | — | (2.47) | (154.72) | (43.84) | (15.17) | (4.83) | |||||
| Cash flow | — | — | — | — | — | (3.38) | (58.61) | (22.75) | (5.47) | (2.33) | |||||
| Capex | — | — | — | — | — | 0.00 | (0.12) | (0.08) | 0.00 | (0.01) | |||||
| Free cash flow | — | — | — | — | — | (3.38) | (58.73) | (22.83) | (5.47) | (2.34) | |||||
| Book value | — | — | — | — | — | (35.70) | (108.97) | 67.44 | (6.62) | (4.10) | |||||
| Shares, m | — | — | — | — | — | 0 | 0 | 0 | 1 | 1 | |||||
| Valuation, × | |||||||||||||||
| Valuation, × | P/E | — | — | — | — | — | — | — | — | 0.00 | 0.00 | ||||
| P/S | — | — | — | — | — | — | — | — | 1.58 | 0.22 | |||||
| P/B | — | — | — | — | — | — | — | — | 0.00 | 0.00 | |||||
| EV/Sales | — | — | — | — | — | — | — | — | 1.93 | 0.64 | |||||
| EV/FCF | — | — | — | — | — | — | — | — | (1.86) | (0.36) | |||||
| Cash, $m | |||||||||||||||
| Cash, $m | Operating cash flow | — | — | — | — | — | 0 | (3) | (8) | (4) | (3) | ||||
| Capex | — | — | — | — | — | — | 0 | 0 | — | 0 | |||||
| Free cash flow | — | — | — | — | — | 0 | (3) | (8) | (4) | (3) | |||||
| Balance, $m | |||||||||||||||
| Balance, $m | Working capital | — | — | — | — | — | 1 | (7) | 24 | (5) | (6) | ||||
| Total debt | — | — | — | — | — | — | — | — | — | — | |||||
| Net debt | — | — | — | — | — | (1) | 0 | (3) | 0 | (1) | |||||
| Shareholders’ equity | — | — | — | — | — | (5) | (6) | 25 | (5) | (6) | |||||
| Returns, % | |||||||||||||||
| Returns, % | ROA | — | — | — | — | — | (0.42) | (12.23) | (49.08) | (31.70) | (359.56) | ||||
| ROIC | — | — | — | — | — | 0.00 | 0.00 | (17.01) | 0.00 | 0.00 | |||||
| ROE | — | — | — | — | — | 0.00 | 45.16 | 247.23 | (103.50) | 130.54 | |||||
Negative figures in brackets.
Fiscal years to Dec 2025 · latest quarter Jun 2026
Charts ten years each
Longevity Health Holdings, Inc. vs peers in Household & Personal Products (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| SLSN Solesence, Inc. | $62.8M | — (loss-making) | — | −24.69% (below 0%: shrinking) | n/m | +86.52% (above 0%: growing) | 30.97% | 0.79% | Compare |
| GROV Grove Collaborative Holdings, Inc. | $42.5M | — (loss-making) | — (loss-making) | −16.94% (below 0%: shrinking) | n/m | +101.08% (above 0%: growing) | 53.56% | (2.14%) | Compare |
| UG United-Guardian, Inc. | $31.5M | 12.7× | 18.7× | +9.52% (above 0%: growing) | +14.29% (above 0%: growing) | +428.43% (above 0%: growing) | 49.73% | 24.26% | Compare |
| DSY Big Tree Cloud Holdings Limited | $27.3M | 18.1× | — | — | 0.00% | −267.22% (below 0%: shrinking) | — | — | Compare |
| ATTT Atlas Trinity Tech Limited | $15.3M | — | — | — | — | −192.00% (below 0%: shrinking) | — | — | Compare |
| BRSHF Bruush Oral Care Inc. | $8.7M | — (loss-making) | — | +7.78% (above 0%: growing) | n/m | −241.22% (below 0%: shrinking) | 75.64% | (488.63%) | Compare |
| TANH Tantech Holdings Ltd. | $8.6M | — (loss-making) | 0.7× | −4.32% (below 0%: shrinking) | +102.50% (above 0%: growing) | −214.50% (below 0%: shrinking) | 20.52% | 0.00% | Compare |
| BYAH Park Ha Biological Technology Co., Ltd. | $5.6M | — | — | — | — | −138.75% (below 0%: shrinking) | — | — | Compare |
| XAGE Longevity Health Holdings, Inc. | $1.6M | — (loss-making) | — | −21.37% (below 0%: shrinking) | n/m | +73.22% (above 0%: growing) | 59.47% | (182.88%) | |
| Median of peers | $21.3M | — | — | −4.32% | +14.29% | −165.37% | 49.73% | 0.00% |
Longevity Health Holdings, Inc. (XAGE) key facts
- Strength: Longevity Health Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 million, up 3,702.8% from fiscal 2024.
- Longevity Health Holdings, Inc. (XAGE) is a Household & Personal Products company in the Consumer Defensive sector.
- As of October 15, 2026, XAGE traded at $0.11, a market capitalization of $1.6 million.
- Return on equity was 130.5% and debt-to-equity 0.00.
- Its Altman Z-score is −56.91 (distress zone) for fiscal 2025.